Literature DB >> 6084782

Beta-adrenoceptor subtypes in human, rat, guinea pig, and rabbit atria.

C Wilson, C Lincoln.   

Abstract

Selective beta-adrenoceptor agonists and antagonists were used to characterize the beta-adrenoceptor subtypes in human right atrium. The activity order of selective agonists for rat, guinea pig, and rabbit atrial inotropic and chronotropic responses was consistent with the hypothesis that only beta 1-adrenoceptors mediate these responses. In human right atrium, however, the beta 2-selective agonists fenoterol and salbutamol were relatively much more active. The beta 1-selective antagonist practolol preferentially antagonized the human atrial response to noradrenaline (beta 1-selective) as opposed to fenoterol (beta 2-selective), whereas the beta 2-selective antagonist ICI 118,551 preferentially antagonized the response to fenoterol. The data indicate that the response of human right atrium to beta-adrenoceptor agonists is mediated by a mixed beta 1-plus beta 2-adrenoceptor population. The implications of these results with respect to the therapeutic uses of beta-adrenoceptor agonists are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6084782

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  14 in total

1.  Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.

Authors:  A Grove; B J Lipworth
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

2.  Electrophysiological effects mediated by the stimulation of cardiac beta 2-adrenoceptors with tulobuterol.

Authors:  A Mugelli; S Amerini; P De Bonfioli Cavalcabo; E Cerbai; S Visentin
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

Review 3.  Dose-response of inhaled drugs in asthma. An update.

Authors:  D J Clark; B J Lipworth
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

4.  Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.

Authors:  B J Lipworth; D M Newnham; R A Clark; D P Dhillon; J H Winter; D G McDevitt
Journal:  Thorax       Date:  1995-01       Impact factor: 9.139

5.  Beta-adrenoceptor blocking effects of a selective beta 2-agonist, mabuterol, on the isolated, blood-perfused right atrium of the dog.

Authors:  K Akahane; Y Furukawa; Y Ogiwara; M Haniuda; S Chiba
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

6.  Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.

Authors:  A Grove; L C McFarlane; B J Lipworth
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

7.  Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.

Authors:  D M Newnham; N M Wheeldon; B J Lipworth; D G McDevitt
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

8.  Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: a combined patch-clamp and binding study.

Authors:  E Cerbai; L Guerra; K Varani; M Barbieri; P A Borea; A Mugelli
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

9.  The role of cyclic AMP in the positive inotropic effect mediated by beta 1- and beta 2-adrenoceptors in isolated human right atrium.

Authors:  K Ikezono; M C Michel; H R Zerkowski; J J Beckeringh; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

Review 10.  Is the ISA of pindolol beta 2-adrenoceptor selective?

Authors:  W H Aellig; B J Clark
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.